Bafna Pharmaceuticals shareholding pattern

BAFNAPH

HealthcareSmall

114.89

5.47 (5.00%)
Last updated on 18 Aug, 2025 | 15:25 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bafna Pharmaceuticals Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

88.3%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

11.7%

Others

0%

Total Promoters
MAR '24
88.3%
JUN '24
88.3%
SEP '24
88.3%
DEC '24
88.3%

Bafna Pharmaceuticals FAQs

As of 08-2025, the promoter shareholding in Bafna Pharmaceuticals stands at 75% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Bafna Pharmaceuticals is 9.34% and 0% respectively.

The retail shareholding of the Bafna Pharmaceuticals is 15.66%.

Changes in shareholding patterns of Bafna Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Bafna Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.